"北交所市值之王"锦波生物（832982.BJ）正迎来重要的战略伙伴。 日前，锦波生物宣布与中国前首富钟睒睒旗下的养生堂有限公司（下称"养生堂"）签署了战略合作协议。 锦波生物将向养生堂发行6.24%的股份，金额不超过20亿元，这有望创下北交所有史以来最大的一笔现金定增。 同时记录还在被刷新。 另一方面，随着养生堂的入股，锦波生物的渠道销售能力有望得到加强。 作为养生堂的核心子公司，农夫山泉（9633.HK）是全国饮料行业的龙头企业，旗下更是覆盖了各省市区的下沉渠道，有望推动锦波生物护肤品 进入更多市场区域。 | | | 北交所公司实控人减持完成一览 | | | | --- | --- | --- | --- | --- | | 公司名称 | 減持者 | 减持比例 | 减持金额 | 日期 | | 路斯股份 | 刘光成 | 0. 55% | 39.51万元 | 2023年5月-2023年11月 | | 梓檀宮 | 内江聚才 | 0.15% | 154.21万元 | 2023年2月 | | 中设咨询 | 刘浪 | 0.51% | 250.83万元 | 2023年2月-2023年7月 | | 锦好医疗 | 锦同盛投 ...

Core Viewpoint - The actual controllers of Greentech Harmonic (688017.SH) have announced a share reduction plan for the first time since the company's IPO in August 2020, indicating potential shifts in shareholder confidence and market dynamics [1][2]. Shareholder Actions - The controlling shareholders, Zuo Jing and Zuo Yuyu, plan to reduce their holdings by up to 2.74 million shares, representing a maximum of 3% of the total shares [1]. - The reduction will occur through a combination of centralized bidding (up to 1%) and block trading (up to 2%) [1]. - Currently, the two brothers hold a combined total of 68.91 million shares, accounting for 37.6% of the company's total equity [1]. Financial Performance - In 2024, Greentech Harmonic reported revenue of 387 million yuan, an increase of 8.77% year-on-year, while net profit decreased by 33.26% to 56.17 million yuan, marking three consecutive years of declining profits [2]. - The decline in net profit is attributed to reduced cash management income, lower fiscal subsidies, and increased expenses related to new product development and overseas market expansion [2]. - The company's core product, harmonic reducers, generated revenue of 325 million yuan in 2024, reflecting a year-on-year growth of 2.56% [3]. Profitability Trends - The overall gross margin for Greentech Harmonic has been declining, with rates of 48.69%, 41.14%, and 37.54% from 2022 to 2024, respectively [4]. - In the first quarter of 2025, the company achieved revenue of 98.03 million yuan, a year-on-year increase of 19.65%, with net profit slightly increasing by 0.66% to 20.25 million yuan [4].